Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers

  • Authors:
    • Takao Itoi
    • Yasushi Shinohara
    • Kazuya Takeda
    • Kazuto Nakamura
    • Masafumi Shimizu
    • Kazuma Ohyashiki
    • Hisashi Hisatomi
    • Hiroto Nakano
    • Fuminori Moriyasu
  • View Affiliations

  • Published online on: March 1, 2001     https://doi.org/10.3892/ijmm.7.3.281
  • Pages: 281-287
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Human telomerase reverse transcriptase (hTERT), which codes for the catalytic subunit of telomerase, is essential for telomerase activity. Recent studies revealed that levels of hTERT mRNA as well as telomerase activity are high in neoplasm. The purpose of this study was to correlate the expression of hTERT mRNA with telomerase activity in biopsy specimens and bile from biliary tract cancers and to evaluate the potential diagnostic value of hTERT mRNA analysis for biliary malignancy. We analyzed hTERT mRNA and telomerase activity in biopsy specimens and exfoliated bile cells from patients with cholangiocarcinoma, gallbladder carcinoma and bile duct stones. hTERT was detected by either nested reverse transcriptase-polymerase chain reaction (PCR) or real-time PCR. Telomerase activity was examined by a fluorescence-based telomeric repeat amplification protocol assay. Six of 10 malignant biopsy specimens had detectable hTERT and 7 of 10 had telomerase activity. All cases with hTERT expression had telomerase activity. In bile, 7 of 10 malignant patients had detectable hTERT and 3 of 10 had telomerase activity. Importantly, there were no false positive results in tissue specimens or bile examined in 6 non-cancerous cases. In conclusion, the detection of hTERT mRNA in biopsy specimens and bile cells, in combination with routine histologic and cytologic examination may improve the diagnosis of biliary tract cancers.

Related Articles

Journal Cover

March 2001
Volume 7 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Itoi T, Shinohara Y, Takeda K, Nakamura K, Shimizu M, Ohyashiki K, Hisatomi H, Nakano H and Moriyasu F: Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers. Int J Mol Med 7: 281-287, 2001.
APA
Itoi, T., Shinohara, Y., Takeda, K., Nakamura, K., Shimizu, M., Ohyashiki, K. ... Moriyasu, F. (2001). Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers. International Journal of Molecular Medicine, 7, 281-287. https://doi.org/10.3892/ijmm.7.3.281
MLA
Itoi, T., Shinohara, Y., Takeda, K., Nakamura, K., Shimizu, M., Ohyashiki, K., Hisatomi, H., Nakano, H., Moriyasu, F."Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers". International Journal of Molecular Medicine 7.3 (2001): 281-287.
Chicago
Itoi, T., Shinohara, Y., Takeda, K., Nakamura, K., Shimizu, M., Ohyashiki, K., Hisatomi, H., Nakano, H., Moriyasu, F."Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers". International Journal of Molecular Medicine 7, no. 3 (2001): 281-287. https://doi.org/10.3892/ijmm.7.3.281